Mostrar el registro sencillo del ítem

Elvitegravir-Cobicistat-Emtricitabine-Tenofovir Alafenamide Single-tablet Regimen for Human Immunodeficiency Virus Postexposure Prophylaxis

dc.rights.licenseopenen_US
dc.contributor.authorGANTNER, P.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorHESSAMFAR, Mojgan
dc.contributor.authorSOUALA, M. F.
dc.contributor.authorVALIN, N.
dc.contributor.authorSIMON, A.
dc.contributor.authorAJANA, F.
dc.contributor.authorBOUVET, E.
dc.contributor.authorROUVEIX, E.
dc.contributor.authorCOTTE, L.
dc.contributor.authorBANI-SADR, F.
dc.contributor.authorHUSTACHE-MATHIEU, L.
dc.contributor.authorLEBRETTE, M. G.
dc.contributor.authorTRUCHETET, F.
dc.contributor.authorGALEMPOIX, J. M.
dc.contributor.authorPIROTH, L.
dc.contributor.authorPELLISSIER, G.
dc.contributor.authorMURET, P.
dc.contributor.authorREY, D.
dc.date.accessioned2021-01-25T15:35:52Z
dc.date.available2021-01-25T15:35:52Z
dc.date.issued2020
dc.identifier.issn1058-4838en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/25998
dc.description.abstractEnWe evaluated an elvitegravir–cobicistat–emtricitabine–tenofovir alafenamide single-tablet regimen for human immunodeficiency virus postexposure prophylaxis. The completion rate and adherence were good, and the tolerance was acceptable; no seroconversion was observed. We confirm that this regimen could be appropriate for postexposure prophylaxis.
dc.language.isoENen_US
dc.subjectMORPH3Eus
dc.title.enElvitegravir-Cobicistat-Emtricitabine-Tenofovir Alafenamide Single-tablet Regimen for Human Immunodeficiency Virus Postexposure Prophylaxis
dc.title.alternativeClin Infect Disen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1093/cid/ciz577en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed31804669en_US
bordeaux.journalClinical Infectious Diseasesen_US
bordeaux.page943-946en_US
bordeaux.volume70en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.issue5en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamMORPH3Eusen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03120641
hal.version1
hal.date.transferred2021-01-25T15:35:58Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Clinical%20Infectious%20Diseases&rft.date=2020&rft.volume=70&rft.issue=5&rft.spage=943-946&rft.epage=943-946&rft.eissn=1058-4838&rft.issn=1058-4838&rft.au=GANTNER,%20P.&HESSAMFAR,%20Mojgan&SOUALA,%20M.%20F.&VALIN,%20N.&SIMON,%20A.&rft.genre=article


Archivos en el ítem

ArchivosTamañoFormatoVer

No hay archivos asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem